Reliability of point-of-care testing of INR in acute stroke

Canadian Journal of Neurological Sciences

Volumn 35, Issue 3, 2008, Pages 348-351

  Green, Theresa L ^a   Mansoor, Adnan ^a   Newcommon, Nancy ^a   Stephenson, Caroline ^a   Stewart, Eileen ^a   Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DIAGNOSTIC ACCURACY; EMERGENCY WARD; FEMALE; HEALTH CARE FACILITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; RELIABILITY; VALIDITY; VOLUNTEER;

EID: 51349153816     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008945     Document Type: Article

References (19)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med. 1995;333:1581-7.
2. Furlan A, Higadasha R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003-11.
3. Hylek E, Go A, Chang Y, Jensvold N, Henault L, Selby J, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Eng J Med. 2003;349:1019-26.
4. van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis. 2001;12:35-40.
5. Cachia P, McGregor E, Adlakha S, Davey P, Goudie B. Accuracy and precision of the TAS analyser for near-patient INR testing by non-pathology staff in the community. J Clin Pathol. 1998; 51:68-72.
6. Hirsch J, Wendt T, Kuhly P, Schaffartzik W. Point-of-care testing apparatus. Measurement of coagulation. Anaesthesia. 2001;56: 760-3.
7. Oral Anticoagulation Monitoring Study Group. Prothrombin measurement using a patient self-testing system. Oral Anticoagulation Monitoring Study Group: Am J Clin Pathol. 2001;115:280-7.
8. Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Am J Clin Pathol. 2001;115(2):288-96.
9. Plaza-Costa A, Garcia-Romero P, Poveda-Roda R, Bagan JV, Silvestre-Donat FJ, Cervero JA. A comparative study between INR and the determination of prothrombin time with the Coaguchek(r) portable coagulometer in the dental treatment of anticoagulated patients. Medicina Oral. 2002;7(2):130-5.
10. Murray E, Greaves M. INR and point of care testing. BMJ. 2003;327:5-6.
11. Sciach C, Campbell B, Poller L, Keown M, Chauhan N. Reliability of point-of-care prothombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing. Br J Haematol. 2002;119:370-5.
12. Havrda D, Hawk T, Marvin C. Accuracy and precision of the Coaguchek S versus laboratory INRs in a clinic. Ann Pharmacother. 2006;36:769-75.
13. Lizotte A, Quessy I, Vanier MC, Martineau J, Caron S, Darveau M, et al. Reliability, validity and ease of use of a portable point-of-care coagulation device in a pharmacist-managed anti-coagulation clinic. J Thromb Thrombolysis. 2002;14(3):247-54.
14. Douketis J, Lane E, Milne J, Ginsberg J. Accuracy of a portable international normalized ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res. 1998;92:11-17.
15. Cote R, Roussin A, Sharma M, Oliva V, deVeber G, Teal P. Thrombolysis for Acute Ischemic Stroke. 2007 Available from: http://www.tigc.org/ eguidelines/thrombolysisachutestroke07.htm
16. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Circulation. 1996 Sep1;94(5): 1167-74.
17. Sanders K, Lewis S, Cooper S, England J. An evaluation of the Nycomed Thrombutrate system. London: NHS Procurement Directorate; 1989.
18. Gosselin R, Owings J, White R, Hutchinson R, Branch J, Mahackian K, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost. 2000;89: 698-703.
19. Katz B, Marques M. Point-of-care testing in oral anticoagulation: what is the point? MLO Med Lab Obs. 2004;31-4.